Obsessive-Compulsive and Related Disorders

Latest News

Trichotillomania: Diagnosis, Treatment, and Prognosis of a Complex Psychiatric Disorder

The pathology, diagnosis, and treatment of the complex disorder, trichotillomania, is reviewed.

Modifying Treatment for OCD Patients During COVID-19

This clinical review assessed the use of exposure and response prevention therapy for patients with obsessive-compulsive disorder during the COVID-19 pandemic.

OCD Patients With Increased Brain Activity May Respond Better to CBT

This study examines whether pretreatment brain activation during cognitive control and reward processing is associated with treatment response to CBT in patients with OCD.

Treatment Expectancy, Motivation Linked to CBT Response in Body Dysmorphic Disorder

In body dysmorphic disorder, the higher a patient’s readiness to change and confidence in cognitive behavioral therapy, the more likely the intervention will be successful.

Cognitive Behavioral Therapy, Supportive Psychotherapy Effective Treatment for Body Dysmorphic Disorder Symptoms

Cognitive behavioral therapy and supportive psychotherapy can improve body dysmorphic disorder symptoms, but cognitive behavioral therapy is associated with more consistent improvements.

Cognitive Ability May Help Differentiate OCD From Generalized Anxiety in Children

A study compared participants with clear diagnoses of either generalized anxiety disorder or obsessive-compulsive disorder with each other, as well as with controls, in order to identify cognitive differences between both groups.

Examining Predictors of OCD Treatment Response Trajectory

Intensive residential treatment was found to be effective in reducing the symptoms of obsessive-compulsive disorder, although different response trajectories were observed.

TMS Device Cleared to Treat Obsessive Compulsive Disorder

Transcranial magnetic stimulation (TMS) uses magnetic fields to stimulate nerve cells in the brain.

Examining Whether Adjunctive Glutamatergic Medication Further Eases OCD Symptoms

Researchers examined whether adjunctive gabapentin or memantine and standard treatment with a selective serotonin-reuptake inhibitor (SSRI) might lead to further improvements in patients with OCD.

FDA Permits Marketing of Brain Stimulation Device for OCD

A brain stimulation device to treat OCD has received approval for marketing by the US Food and Drug Administration.